MRI in Randomised Cohorts of Asymptomatic AS
Key facts
- Who runs it
- University of Leicester
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 202 people enrolled
- Started
- 28 Jul 2021
- Ended
- 12 May 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Surgical/ Transcatheter aortic valve replacement
- Record updated
- 29 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Willing to and able to consent
- Participant in an RCT randomising patients with asymptomatic severe AS to early AVR vs standard care
- Severe aortic stenosis, as defined by original trial's inclusion criteria
- Asymptomatic at the time of randomisation in the RCT
- Willingness to have 1-2 cardiac MRI scan(s)
Who cannot take part
- eGFR <30
- Contra-indication to MRI
- Severe claustrophobia (precluding MRI)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Aortic stenosis is narrowing of the aortic valve, and is the commonest type of valve disease requiring surgery. Current guidelines recommend waiting till patients develop symptoms (chest pain, breathlessness and dizzy spells/fainting) before possible open heart surgery to replace the valve is offered. However, studies using detailed 'MRI' scanning of the heart have shown that up to half of the patients already have 'scarring' in the heart by the time symptoms develop. Furthermore, scarring is not fully reversed even after surgery and is associated with worse outcome. This suggests that some patients are being offered treatment too late. Two randomised trials in the UK (EASY AS and EVOLVED) are currently investigating if valve replacement before symptoms will result in better survival. The aim of this study is to compare the effect of early valve replacement versus waiting for symptoms, on the amount of scarring in the heart. The investigators want to know if early treatment leads to less overall scarring at the end, and leads to better quality of life and recovery after surgery. The investigators will invite participants of the EASY AS and EVOLVED trials to have 1-2 MRI heart scans: at recruitment and 2 years after being randomly allocated to early aortic valve replacement vs 'watchful waiting'. The investigators will also assess the impact of the two treatment approaches on quality of life, disability-free survival (using questionnaires) and recovery after surgery. The results from this project will increase understanding of the results of the main trials, and lead to improved selection of patients with aortic stenosis who are likely to benefit from early surgery.
The 2 groups in the trial
- Early aortic valve replacement
Asymptomatic severe aortic stenosis patients randomised to early aortic valve replacement
Treatment: Surgical/ Transcatheter aortic valve replacement
- Standard care
Asymptomatic severe aortic stenosis patients randomised to 'watchful waiting' until symptom onset.
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Early Valve Replacement on Myocardial Scar in Asymptomatic Aortic Stenosis: an Observational MRI Study of Randomised Cohorts
- Record updated
- 29 July 2026